年間 6 号発行
ISSN 印刷: 1040-8401
ISSN オンライン: 2162-6472
Indexed in
Dendritic Cells in Cancer Immunotherapy
要約
Antigen presentation is a critical regulatory element for the induction of cellular immune responses. Thus, one of the principal current goals of tumor immunotherapy is to control and enhance tumor antigen presentation. In this respect, dendritic cells (DC) are now being widely investigated as immunotherapeutic agents for the treatment of disseminated malignancies. At present, numerous ways to employ DCs for tumor immunotherapy are being tested, ranging from direct in situ expansion and activation of DCs to adoptive transfer of ex vivo generated DCs, and numerous techniques have been designed to optimize DC activation, tumor antigen delivery to DCs, and induction of tumor-specific, as well as helper immune responses, in vivo. However, the results of recent preclinical studies and the diversity of the clinical phase I trials that are currently underway indicate that little is still known about the exact mechanisms by which DCs modulate tumor immunity and pose the concern that premature clinical trials might not yield the desired results and might be harmful to, rather than promote, the concept of DC-based tumor immunotherapy. This review summarizes some of the current approaches to induce tumor immunity by DC-based vaccination and discusses their advantages and concerns.
-
Zhong Hua, Shurin Michael R, Han Baohui, Optimizing dendritic cell-based immunotherapy for cancer, Expert Review of Vaccines, 6, 3, 2007. Crossref
-
Chen Zhuang, Xia Dajing, Bi Xuguang, Saxena Anurag, Sidhu Narinder, El-Gayed Ali, Xiang Jim, Combined radiation therapy and dendritic cell vaccine for treating solid tumors with liver micro-metastasis, The Journal of Gene Medicine, 7, 4, 2005. Crossref
-
Aly Hamdy A.A., Cancer therapy and vaccination, Journal of Immunological Methods, 382, 1-2, 2012. Crossref
-
Schiller Meinhard, Metze Dieter, Luger Thomas A., Grabbe Stephan, Gunzer Matthias, Immune response modifiers ? mode of action, Experimental Dermatology, 15, 5, 2006. Crossref
-
Shrivastava Pratima, Singh Sukh Mahendra, Singh Nisha, Effect of thymosin alpha 1 on the antitumor activity of tumor-associated macrophage-derived dendritic cells, Journal of Biomedical Science, 11, 5, 2004. Crossref
-
Zhong G., Wang J., Xu M., Xie Z., Yu M., Wang J., Zhou T., Gong W., Sun Y., Hu M., Zhang X., Shen B., Guo N., Enhanced Maturation and Functional Capacity of Dendritic Cells Induced by Mannosylated L2 Domain of ErbB2 Receptor, Scandinavian Journal of Immunology, 62, 2, 2005. Crossref
-
Tumor Vaccination, in Encyclopedic Dictionary of Genetics, Genomics and Proteomics, 2004. Crossref
-
Peng Shiwen, Kim Tae Woo, Lee Jin Hyup, Yang Mu, He Liangmei, Hung Chien-Fu, Wu T.-C., Vaccination with Dendritic Cells Transfected with BAK and BAX siRNA Enhances Antigen-Specific Immune Responses by Prolonging Dendritic Cell Life, Human Gene Therapy, 16, 5, 2005. Crossref
-
Ridolfi Ruggero, Ridolfi Laura, Petrini Massimiliano, Fiammenghi Laura, Riccobon Angela, Dendritic cell vaccination and immunostimulation in advanced melanoma, Expert Review of Vaccines, 2, 6, 2003. Crossref
-
Kang Tae Heung, Lee Jin Hyup, Noh Kyung Hee, Han Hee Dong, Shin Byung Cheol, Choi Eun Young, Peng Shiwen, Hung Chien-Fu, Wu T.-C., Kim Tae Woo, Enhancing dendritic cell vaccine potency by combining a BAK/BAX siRNA-mediated antiapoptotic strategy to prolong dendritic cell life with an intracellular strategy to target antigen to lysosomal compartments, International Journal of Cancer, 120, 8, 2007. Crossref
-
Bohnenkamp Hermann R., Coleman Julia, Burchell Joy M., Taylor-Papadimitriou Joyce, Noll Thomas, Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1-specific CD8+ T cells identified by peptide-MHC-class-I tetramers, Cellular Immunology, 231, 1-2, 2004. Crossref
-
Harui Airi, Roth Michael D., Sanghvi Mihir, Vira Darshni, Mizuguchi Hiroyuki, Basak Saroj K., Centrifugation enhances integrin-mediated transduction of dendritic cells by conventional and RGD-modified adenoviral vectors, Journal of Immunological Methods, 312, 1-2, 2006. Crossref
-
Gunzer Matthias, Jänich Sabine, Varga Georg, Grabbe Stephan, Dendritic cells and tumor immunity, Seminars in Immunology, 13, 5, 2001. Crossref
-
Lee Seung Jun, Shin Sung Jae, Lee Moon Hee, Lee Min-Goo, Kang Tae Heung, Park Won Sun, Soh Byoung Yul, Park Jung Hee, Shin Yong Kyoo, Kim Han Wool, Yun Cheol-Heui, Jung In Duk, Park Yeong-Min, Gao Jian-Xin, A Potential Protein Adjuvant Derived from Mycobacterium tuberculosis Rv0652 Enhances Dendritic Cells-Based Tumor Immunotherapy, PLoS ONE, 9, 8, 2014. Crossref
-
Zhang Jin-Kun, Antitumor immunopreventive and immunotherapeutic effect in mice induced by hybrid vaccine of dendritic cells and hepatocarcinomain vivo, World Journal of Gastroenterology, 9, 3, 2003. Crossref
-
Barabas Arpad Z., Cole Chad D., Graeff Richard M., Morcol Tulin, Lafreniere Rene, Shoenfeld Yehuda, A novel modified vaccination technique produces IgG antibodies that cause complement-mediated lysis of multiple myeloma cells carrying CD38 antigen, Human Antibodies, 24, 3-4, 2017. Crossref
-
Gilboa Eli, The promise of cancer vaccines, Nature Reviews Cancer, 4, 5, 2004. Crossref
-
Antigen Presentation by Dendritic Cells and Their Significance in Anti-Neoplastic Immunotherapy, in Molecular Markers of Brain Tumor Cells, 2005. Crossref
-
Thymic Accessory Cells, Including Dendritic Type Antigen Presenting Cells, within the Mammalian Thymic Microenvironment, in Immunological Aspects of Neoplasia — The Role of the Thymus, 17, 2004. Crossref
-
Korokhov Nikolay, Noureddini Sam C., Curiel David T., Santegoets Saskia J. A. M., Scheper Rik J., de Gruijl Tanja D., A Single-Component CD40-Targeted Adenovirus Vector Displays Highly Efficient Transduction and Activation of Dendritic Cells in a Human Skin Substrate System, Molecular Pharmaceutics, 2, 3, 2005. Crossref
-
Beckebaum Susanne, Zhang Xia, Chen Xiao, Yu Zhengya, Frilling Andrea, Dworacki Grzegorz, Grosse-Wilde Hans, Broelsch Christoph Erich, Gerken Guido, Cicinnati Vito R., Increased Levels of Interleukin-10 in Serum from Patients with Hepatocellular Carcinoma Correlate with Profound Numerical Deficiencies and Immature Phenotype of Circulating Dendritic Cell Subsets, Clinical Cancer Research, 10, 21, 2004. Crossref
-
Liu Shanrong, Foster Barbara A., Chen Tie, Zheng Guoxing, Chen Aoshuang, Modifying Dendritic Cells via Protein Transfer for Antitumor Therapeutics, Clinical Cancer Research, 13, 1, 2007. Crossref
-
Zhu Bohui, Sun Yiyuan, Wei Xiaoqing, Zhou Huibin, Cao Jingchen, Li Chenwei, Wu Ning, Leung Man Fai, Dendritic Cell Vaccine Loaded with MG-7 Antigen Induces Cytotoxic T Lymphocyte Responses against Gastric Cancer, Journal of Healthcare Engineering, 2022, 2022. Crossref
-
Jung In Duk, Jeong Soo Kyung, Lee Chang-Min, Noh Kyung Tae, Heo Deok Rim, Shin Yong Kyoo, Yun Cheol-Heui, Koh Won-Jung, Akira Shizuo, Whang Jake, Kim Hwa-Jung, Park Won Sun, Shin Sung Jae, Park Yeong-Min, Enhanced Efficacy of Therapeutic Cancer Vaccines Produced by Co-Treatment with Mycobacterium tuberculosis Heparin-Binding Hemagglutinin, a Novel TLR4 Agonist, Cancer Research, 71, 8, 2011. Crossref
-
Wei Huafeng, Wang Hao, Lu Bing, Li Bohua, Hou Sheng, Qian Weizhu, Fan Kexing, Dai Jianxin, Zhao Jian, Guo Yajun, Cancer Immunotherapy Using In vitro Genetically Modified Targeted Dendritic Cells, Cancer Research, 68, 10, 2008. Crossref
-
Mullins David W., Engelhard Victor H., Limited Infiltration of Exogenous Dendritic Cells and Naive T Cells Restricts Immune Responses in Peripheral Lymph Nodes, The Journal of Immunology, 176, 8, 2006. Crossref
-
Roth Michael D., Cheng Qingwen, Harui Airi, Basak Saroj K., Mitani Kohnosuke, Low Teresa A., Kiertscher Sylvia M., Helper-Dependent Adenoviral Vectors Efficiently Express Transgenes in Human Dendritic Cells but Still Stimulate Antiviral Immune Responses, The Journal of Immunology, 169, 8, 2002. Crossref
-
Nair Smita, McLaughlin Catherine, Weizer Alon, Su Zhen, Boczkowski David, Dannull Jens, Vieweg Johannes, Gilboa Eli, Injection of Immature Dendritic Cells into Adjuvant-Treated Skin Obviates the Need for Ex Vivo Maturation, The Journal of Immunology, 171, 11, 2003. Crossref